The pandemic is making M&A due diligence even more important. Here’s what you need to know.
COVID-19 has caused mergers and acquisition volume to drop to levels not seen in more than a decade. But that’s not the only change, as M&A due diligence will look different going forward. That’s according to BRG Managing Director Andrew Eckstein, who works with companies on buy- and sell-side diligence for middle-market healthcare transactions. We asked Eckstein about his predictions for the coming months.
Read the full Q&A in ThinkSet.